Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma. - Wikidata - wikimedia - TriplyDB

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

http://www.wikidata.org/entity/Q34904867

about

Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor--[(18)F]Fluorooctyl Fenbufen Amide--For Imaging of Brain Tumors.A selective cyclooxygenase-2 inhibitor (Etodolac) prevents spontaneous biliary tumorigenesis in a hamster bilioenterostomy model.

P2860

Q36407288-CF8889ED-069D-4DD8-A9EF-D5065E5ABEAC Q36962011-F713A089-8D5A-41CC-AD77-ACCF8A76C60A Q38812588-F5302CAF-C701-4BA9-9BAB-6B7AB6E54086 Q48810894-597A92E8-857E-465C-9D72-AE26F65E91B1 Q51748783-0A09A15E-3566-4265-9F13-58DE88A484BD

P2860

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

http://www.wikidata.org/entity/Q34904867

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@ast

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@en

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@nl

type

label

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@ast

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@en

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@nl

prefLabel

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@ast

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@en

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.

@nl

P1433

Q34904867-86B9869F-CEC1-42ED-AC1F-896A3EFC89E5

P1476

Q34904867-6CA19540-B866-4BD5-BE56-8D7EA2B1DE15

P2093

Q34904867-5556F078-8643-4292-8491-87E3D28175C4

Q34904867-62ECFFF0-070A-4858-8CCE-AD95A133F403

Q34904867-6F0BF34D-3952-4E22-86EC-7A308A44A4EB

Q34904867-72BE3E1C-6946-45A9-B491-ADB386BBF0B8

Q34904867-C200BAE3-4034-4251-A112-C1C4FE9164D1

Q34904867-E8837F2E-ABE1-4D4E-91EE-08796EA74FB8

P2860

Q34904867-018F9D68-E431-43F0-8BA1-281B4DE69AED

Q34904867-0AED4254-5B0E-40A3-9C80-2904420F050F

Q34904867-0B836511-696A-4824-AA1E-94897C16F058

Q34904867-0C58D055-434C-4E48-BDC9-BE20DDF53101

Q34904867-0F93758E-B95B-416A-A67B-C830F983303D

Q34904867-1E46D679-A286-44E2-8442-7895E97685C4

Q34904867-283AD60D-EA10-4A4C-8E36-D07221E33474

Q34904867-2B75B9A5-432B-44F2-8787-0809E2836BEE

Q34904867-2DBBB40D-2F3C-4C0C-B856-676889D90F10

Q34904867-33A380FC-C817-4CE3-9A87-72364D4BCFA5

P304

Q34904867-B024CE24-2DCB-4D60-BDC1-0204B796E8CE

P31

Q34904867-F32617AC-BA93-428B-BD80-F56BF53D613B

P356

Q34904867-7962271A-DF24-4597-A903-F15A0A444C83

P407

Q34904867-368C39D8-4EF9-41A3-ABE2-0709B848D256

P433

Q34904867-F560E95C-5260-4F3C-8DA6-B8CE8CF4763F

P478

Q34904867-55765AD6-78AB-425C-B889-6E8F877BDAC0

P50

Q34904867-02C03F9C-6A5D-48E3-BA2E-2D7706A30BA0

Q34904867-203704F0-622E-4817-9916-F944CBFFEBB0

P577

Q34904867-7E5446C0-868A-49F5-9A8B-559FDA0F36FD

P5875

Q34904867-EC9C9322-DF28-4582-9624-690DD717E44A

P698

Q34904867-800AF1E0-FE47-46D7-A044-4DF032A3722E

P921

Q34904867-73467ACE-1808-4B71-A848-D6FC14E9DA68

P932

Q34904867-F321F02C-F200-423C-9A2E-0A8938B25E56

P356

JOURNAL.PONE.0069928

P1433

P1476

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma

@en

P2093

Chun-Nan Yeh

http://www.w3.org/2001/XMLSchema#string

Chung-Shan Yu

http://www.w3.org/2001/XMLSchema#string

Jong-Hwei S Pang

http://www.w3.org/2001/XMLSchema#string

Kun-Chun Chiang

http://www.w3.org/2001/XMLSchema#string

Ta-Sen Yeh

http://www.w3.org/2001/XMLSchema#string

Yi-Yin Jan

http://www.w3.org/2001/XMLSchema#string

P2860

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

COX-2 and colon cancer: potential targets for chemoprevention.

AKT plays a central role in tumorigenesis.

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

Changing international trends in mortality rates for liver, biliary and pancreatic tumours.

P304

e69928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0069928

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Horng-Heng Juang

P577

2013-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255695934

http://www.w3.org/2001/XMLSchema#string

P698

23922859

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

3724720

http://www.w3.org/2001/XMLSchema#string